Sign in
Taking peopleNo phase

Preventing foot ulcers in people with type 2 diabetes

Tests ways to prevent diabetic foot ulcers in adults with type 2 diabetes.

Key facts

Who runs it
Istituto Ortopedico Rizzoli
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
Status
Recruiting
People taking part
150 people, planned
Started
3 Nov 2025
Expected to end
15 May 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Full Analysis
  • Partial Analysis
Record updated
21 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who have a risk of foot ulcers (open sores on the foot). It has two groups: people with no past foot ulcer and people whose past foot ulcer has healed.

Age
18 to 75 years
Sex
All sexes
Disease stage
Group 1: type 2 diabetes with mild to moderate risk of foot ulcer (grade 2), and no past foot ulcer. Group 2: type 2 diabetes with diabetic foot and past foot ulcers (grade 3), healed for at least 6 months.
Earlier treatment
People taking medicines that weaken the immune system, or cortisone-based medicines, cannot join.

Main reasons for not taking part

  • Current infection or current cancer
  • Medicines that weaken the immune system, or cortisone-based medicines
  • Pregnancy or breastfeeding
  • Not able to give informed consent
  • Group 1 only: any past or current foot ulcer

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Male and female patients aged between 18 and 75 years
  • Diabetes mellitus type-2 patients with mild to moderate risk of ulceration at the foot (grade 2)
  • Male and female patients aged between 18 and 75 years
  • Patients with diabetes mellitus type-2 and diabetic foot with an history of ulcerative lesions (grade 3), healed for at least 6 months

Who cannot take part

  • Immunosuppressive therapies, and cortisone-based therapy
  • Immunosuppressive therapies, and cortisone-based therapy
  • Infections in progress, ongoing neoplasms
  • Infections in progress, ongoing neoplasms
  • History or evidence of ulcers at the foot
  • Pregnancy and lactation
  • Inability to provide informed consent
  • Pregnancy and lactation
  • Inability to provide informed consent

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2.

The 2 groups in the trial

  • Population 1Other group

    Patients affected by diabetes mellitus type-2 with no previous history of foot ulceration, but with a moderate ulcerative risk.

    Treatment: Full Analysis

  • Population 2Other group

    Patients affected by diabetes mellitus type-2: typical adult subjects affected by diabetic foot, who had foot ulcers and thus in risk grade 3. The ulcerative lesions must have been resolved from at least 6 months, so that there is no longer acute inflammatory process in progress at the time of blood sampling.

    Treatment: Partial Analysis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot
Plain-language title
Preventing foot ulcers in people with type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07021222, who can take part
Publications
Record updated
21 January 2026